Business · 23/02/1998Updated: 10/17/2026 · 1 min read
FDA Proposes Changes to Over-the-Counter Ophthalmic Drug Products
Summary
The Food and Drug Administration (FDA) is proposing to update the final monograph for over-the-counter (OTC) ophthalmic drug products, adding a new warning and revising an existing one for ophthalmic vasoconstrictor products used to treat minor eye irritations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →